China Plans Bureau Merging Drug Regulation With Enforcement Power
This article was originally published in PharmAsia News
China plans to merge the forces of regulation and enforcement in the pharmaceutical and food industries to make the China FDA more effective in policing individual drug makers and their facilities.
You may also be interested in...
Pink Sheet reporters and editors look at the UK MHRA’s surprising approval of the Pfizer/BioNTech coronavirus vaccine, as well as the US reaction, and discuss President-elect Joe Biden’s potential US FDA commissioner nominees.
Divesting the heart valve division will allow LivaNova to focus more resources on its neuromodulation, cardiopulmonary and circulatory support businesses.
The US FDA tells manufacturers in two recent warning letters to get to the root cause of contamination problems and take a more proactive approach to cleaning and equipment maintenance.